Filtered By:
Source: Medicina (Kaunas)
Nutrition: Vitamin A
This page shows you your search results in order of date.
Order by Relevance | Date
Total 463 results found since Jan 2013.
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research
